[8a-S103-1~3] 8.7 Plasma Electronics Invited Talk

9:00 AM - 9:45 AM JST(12:00 AM - 12:45 AM UTC)English Presentation

[8a-S103-1] [Plasma Electronics Invited Talk] Harnessing cold atmospheric plasma species for plasma safety and drug delivery applications

〇Naing Tun Thet¹, Natasha Harwood², Emily Owen⁵, Bethany Patenall⁴, Robert Short³, Toby Jenkins³ (1.Research Fellow, 2.PhD student, 3.Professor, 4.Clin. Sci. Manager, 5.Trainee Pat. Attony)

Keywords:

Cold atmospheric plasma,Drug delivery,Reactive plasma species

Plasma Medicine is an emerging area of research involving the use of cold atmospheric plasma (CAP) which produces a cocktail of reactive oxide and nitride species (RONS), hydroxy radicals, ozone, electric field and ultraviolet. These reactive have antimicrobial and anti-cancer effects and wound healing properties, but some short-lived species and UV are harmful for skin. We developed a plasma-screen hydrogel platform technology that not only allows the delivery of beneficial plasma species but also trigger-releases of antimicrobial, antifungal and anticancer drugs. We believe that our research lies at the interface of cold atmospheric plasma and semi-solid hydrogel, opening many research opportunities at the forefront of cold plasma research for healthcare applications.